News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Christoph Westphal Leaving GlaxoSmithKline (GSK)’s SR One to Focus on Longwood Founders Fund



4/25/2011 9:53:21 AM

Xconomy -- Christoph Westphal, the Boston-based biotech mover/shaker, is leaving GlaxoSmithKline (NYSE: GSK) later this year to focus on Longwood Founders Fund and other business interests, according to a press release this morning. Westphal is currently president of SR One, GSK’s venture capital arm. London-based GSK is also an investor in Longwood Founders Fund, the relatively new VC fund started by Westphal, Michelle Dipp, and Rich Aldrich.

Read at Xconomy


comments powered by Disqus
Xconomy
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES